5 Cancer Research Stories Worth Following – Spring 2017
Cancer research stories worth following this spring include a study on the benefits of one type of immune system therapy for patients with metastatic triple negative breast cancer.
Exploring progress in cancer research from the patient perspective
Cancer research stories worth following this spring include a study on the benefits of one type of immune system therapy for patients with metastatic triple negative breast cancer.
Cancer research stories worth following this winter include a possible new use for an existing drug to prevent metastasis in triple negative breast cancer.
Cancer research stories worth following this fall include new developments in targeted treatment for ovarian cancer and for metastatic breast cancer.
Cancer research stories worth following this summer include reports from ASCO on a web app that improves survival for lung cancer patients and a “biosimilar” treatment for the breast cancer drug Herceptin.
Cancer research stories worth following this spring include a potential new combination treatment for HER2-positive breast cancer and evidence that a gene assay may help breast cancer patients avoid unnecessary chemotherapy treatment.
Cancer research stories worth following this winter include an experimental targeted therapy for metastatic triple negative breast cancer and a study on how the financial toxicity of cancer treatment affects physical health and survival.
What progress is being made toward a blood test or “liquid biopsy” to aid in treatment or early detection of breast cancer?
Research findings presented at the 2015 San Antonio Breast Cancer Symposium may preview an era in which breast cancer treatments will be tailored to each patient.
What’s exciting in cancer research right now? This post reviews several of the most interesting cancer research stories that have been in the news this Fall.
Researchers are developing a vaccine to prevent breast cancer in healthy women, and hope to begin clinical trials within two years.